• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以抗凝血酶III水平衡量左炔诺孕酮(诺普兰)避孕对凝血的影响。

The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.

作者信息

Pryor J A, Cooper K R, Bass J D, Hampton H L, Rock W A, Morrison J C

机构信息

Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson 39216-4505, USA.

出版信息

J Miss State Med Assoc. 1996 Oct;37(10):777-9.

PMID:8908950
Abstract

PURPOSE

To determine the effect of contraception given immediately postpartum on coagulation as measured by antithrombin III.

STUDY DESIGN

In this prospective study, parturients (n = 85) self selected three means of postpartum contraception: levenorgesterol implants, oral contraceptives, or a barrier method.

RESULTS

Baseline coagulation was assessed by antithrombin-III levels in each of the 85 women within 48 hours of delivery (100.35 +/- 1.61%) and at one (109.1 +/- 1.89%) and six (105.51 +/- 1.71%) weeks postpartum. There was a rise in antithrombin-III after delivery but there were no significant differences between the groups.

CONCLUSION

The levenorgesterol implant system did not cause a decrease in antithrombin-III in normal parturients.

摘要

目的

通过抗凝血酶III测定来确定产后立即进行避孕对凝血的影响。

研究设计

在这项前瞻性研究中,产妇(n = 85)自行选择三种产后避孕方法:左炔诺孕酮植入剂、口服避孕药或屏障法。

结果

在85名女性分娩后48小时内(100.35 +/- 1.61%)、产后1周(109.1 +/- 1.89%)和6周(105.51 +/- 1.71%)时,通过抗凝血酶III水平评估基线凝血情况。分娩后抗凝血酶III有所上升,但各组之间无显著差异。

结论

左炔诺孕酮植入系统不会导致正常产妇的抗凝血酶III水平降低。

相似文献

1
The effect of levenogesterol (Norplant) contraception on coagulation as measured by antithrombin-III levels.以抗凝血酶III水平衡量左炔诺孕酮(诺普兰)避孕对凝血的影响。
J Miss State Med Assoc. 1996 Oct;37(10):777-9.
2
Subdermal implants in adolescent mothers.青少年母亲的皮下植入物。
Contracept Rep. 1995 Jul;6(3):14.
3
Preventing repeat adolescent pregnancies with early adoption of the contraceptive implant.通过早期采用避孕植入物预防青少年再次怀孕。
Fam Plann Perspect. 1999 Mar-Apr;31(2):88-93.
4
A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.哺乳期左炔诺孕酮宫内节育系统曼月乐与铜T380A宫内节育器的对比研究:母乳喂养情况、婴儿生长及发育
Contraception. 2005 Nov;72(5):346-51. doi: 10.1016/j.contraception.2005.04.004. Epub 2005 Jul 6.
5
Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.产后即刻使用左炔诺孕酮皮下埋植剂:安全性与耐受性
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):175-9. doi: 10.1016/0002-9378(95)90109-4.
6
Analysis of weight, packed cell volume changes and menstrual pattern in Norplant implant acceptors in Ilorin, Nigeria.尼日利亚伊洛林地区诺普兰皮下埋植剂使用者的体重、红细胞压积变化及月经模式分析。
Niger J Clin Pract. 2007 Jun;10(2):116-9.
7
Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial.产后即刻放置依托孕烯植入剂对产妇止血的影响:一项随机对照试验。
Thromb Res. 2012 Sep;130(3):355-60. doi: 10.1016/j.thromres.2012.03.029. Epub 2012 Apr 28.
8
[Let's talk about Norplant: advances in steroidal contraception].[让我们谈谈诺普兰:甾体避孕法的进展]
Profamilia. 1992 Dec;8(20):28-34.
9
Heparin cofactor II levels are increased by the use of combined oral contraceptives.联合使用口服避孕药会使肝素辅因子II水平升高。
Blood Coagul Fibrinolysis. 1990 Dec;1(6):647-51.
10
Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?预防青少年重复怀孕:产后长效醋酸甲羟孕酮、口服避孕药还是避孕贴片?
J Pediatr Adolesc Gynecol. 2007 Apr;20(2):61-5. doi: 10.1016/j.jpag.2006.11.006.